04:34 PM EDT, 08/30/2024 (MT Newswires) -- Allarity Therapeutics ( ALLR ) said Friday that its shareholders are selling up to 18.5 million shares issued on conversion of series A convertible redeemable preferred stock.
Allarity will not receive any proceeds from the sale and the selling shareholders may offer the shares from time to time, the company said in a registration statement with the US Securities and Exchange Commission.
Shares of the company fell 1.9% in recent after-hours activity.